Alcohol biomarker screening in medical and surgical settings

Peter M. Miller, Claudia Spies, Tim Neumann, Martin A. Javors, A. M. Hoyumpa, John Roache, Amy Webb, Maryam Kashi, Francis E. Sharkey, Raymond F. Anton, Brent M. Egan, Jan Basile, Shaun Nguyen, Michael F. Fleming, Kathryn Sullivan Dillie

Research output: Contribution to journalArticle

23 Scopus citations

Abstract

This article highlights the proceedings of a symposium presented at the 28th Annual Meeting of the Research Society on Alcoholism in Santa Barbara, CA, on June 28, 2005, organized and chaired by Peter Miller. The presentations included (1) Screening for Alcohol Use Disorders in Surgical and Trauma Patients, presented by Claudia Spies; (2) Are Serum Levels of %CDT and GGT Related to Severity of Liver Biopsy Inflammation, Fibrosis, and Steatohepatitis in Patients with Hepatitis C? by Martin Javors; (3) Biochemical Alcohol Screening in the Treatment of Hypertension, presented by Peter Miller; and (4) The Cost-Effectiveness of a New Biomarker, CDT, in a Primary Care Sample, by Michael Fleming. Presentations were discussed by Raymond Anton.

Original languageEnglish (US)
Pages (from-to)185-193
Number of pages9
JournalAlcoholism: Clinical and Experimental Research
Volume30
Issue number2
DOIs
StatePublished - Feb 1 2006

    Fingerprint

Keywords

  • %CDT
  • Alcohol Biomarkers
  • GGT

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Toxicology
  • Psychiatry and Mental health

Cite this

Miller, P. M., Spies, C., Neumann, T., Javors, M. A., Hoyumpa, A. M., Roache, J., Webb, A., Kashi, M., Sharkey, F. E., Anton, R. F., Egan, B. M., Basile, J., Nguyen, S., Fleming, M. F., & Dillie, K. S. (2006). Alcohol biomarker screening in medical and surgical settings. Alcoholism: Clinical and Experimental Research, 30(2), 185-193. https://doi.org/10.1111/j.1530-0277.2006.00029.x